GlassScriptPhysician profile
Ryan M Carr
NPI 1700033917
$52,344.44
in general payments reported to CMS, 2019-2025
16 companies · $661 in 2025
The $661 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24K · 2020: $25K · 2021: $2,721 · 2022: $132 · 2023: $172 · 2024: $194 · 2025: $661.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,027.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,027.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $43,161.02 | 2019-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Gemini Mountain Medical, LLC | $2,170.08 | 2020-2021 | |
| Encore Medical, LP | $2,110.36 | 2019-2025 | Djo Surgical |
| Medacta USA, INC. | $1,487.57 | 2019-2020 | |
| Stryker Corporation | $1,353.79 | 2019-2025 | Aequalis Flex Revive, Blueprint Patient Specific Instrumentation, T2 |
| Medtronic, INC. | $840.00 | 2021 | |
| Zimmer Biomet Holdings, INC. | $409.01 | 2020-2022 | |
| Alliance Medical | $191.41 | 2024-2025 | |
| Conformis, INC. | $179.69 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $178.30 | 2024 | Keytruda, Welireg, Lynparza |
| Uoc USA INC | $106.53 | 2021 | |
| Anika Therapeutics, INC. | $78.68 | 2021 | |
| Avanos Medical | $22.40 | 2023 | On-Q* Pump and Accessories |
| Alexion Pharmaceuticals, INC. | $21.82 | 2025 | Ultomiris |
| Boston Scientific Corporation | $19.21 | 2025 | Angiojet Ultra 5000a |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $14.57 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Carr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.